Critical Analysis: Nanovibronix (FEED) & Its Competitors

Nanovibronix (NASDAQ:FEED) is one of 28 publicly-traded companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it contrast to its peers? We will compare Nanovibronix to related companies based on the strength of its valuation, dividends, analyst recommendations, risk, earnings, institutional ownership and profitability.

Insider & Institutional Ownership

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 5.2% of Nanovibronix shares are held by company insiders. Comparatively, 19.9% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Nanovibronix and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$2.56 million	-$3.70 million	-0.05
Nanovibronix Competitors	$61.66 million	-$32.64 million	5.36

Nanovibronix’s peers have higher revenue, but lower earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Nanovibronix has a beta of 2.26, meaning that its stock price is 126% more volatile than the S&P 500. Comparatively, Nanovibronix’s peers have a beta of 1.80, meaning that their average stock price is 80% more volatile than the S&P 500.

Profitability

This table compares Nanovibronix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Nanovibronix Competitors	-570.12%	-123.56%	-53.83%

Analyst Ratings

This is a breakdown of recent recommendations for Nanovibronix and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	79	79	156	6	2.28

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 39.06%. Given Nanovibronix’s peers stronger consensus rating and higher probable upside, analysts clearly believe Nanovibronix has less favorable growth aspects than its peers.

Summary

Nanovibronix peers beat Nanovibronix on 8 of the 13 factors compared.

Nanovibronix Company Profile

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.